NRIX: Nurix Therapeutics Inc. Common stock Stocks News on October 18, 2024

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

NRIX

GlobeNewswire

a day ago

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

NRIX

MT Newswires

4 days ago

RBC Trims Price Target on Nurix Therapeutics to $26 From $27, Keeps Outperform, Speculative Risk

NRIX

Zacks

6 days ago

Nurix Therapeutics, Inc. (NRIX) Reports Q3 Loss, Lags Revenue Estimates

NRIX

MT Newswires

6 days ago

Nurix Therapeutics Fiscal Q3 Net Loss Narrows, Revenue Falls

Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

NRIX

GlobeNewswire

6 days ago

Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

NRIX

MT Newswires

7 days ago

Jefferies Initiates Coverage on Nurix Therapeutics With Buy Rating, $41 Price Target

Nurix Therapeutics Announces Presentations at ACR Convergence 2024, the Annual Meeting of the American College of Rheumatology

NRIX

GlobeNewswire

9 days ago

Nurix Therapeutics Announces Presentations at ACR Convergence 2024, the Annual Meeting of the American College of Rheumatology

Nurix Therapeutics Announces Presentations at Discovery on Target Conference

NRIX

GlobeNewswire

18 days ago

Nurix Therapeutics Announces Presentations at Discovery on Target Conference

Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit

NRIX

GlobeNewswire

a month ago

Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit

NRIX

Insider Monkey

a month ago

Nurix Therapeutics, Inc. (NRIX): This Small-Cap Healthcare Stock Is A Good Buy Right Now

Nurix Therapeutics to Participate in Upcoming Investor Conferences

NRIX

GlobeNewswire

2 months ago

Nurix Therapeutics to Participate in Upcoming Investor Conferences

NRIX

GuruFocus.com

2 months ago

Insider Sale: CFO Houte Van Sells 20,000 Shares of Nurix Therapeutics Inc (NRIX)

NRIX

MT Newswires

2 months ago

Nurix Therapeutics Insider Sold Shares Worth $504,370, According to a Recent SEC Filing

NRIX

MT Newswires

2 months ago

Oppenheimer Adjusts Nurix Therapeutics Price Target to $27 From $25

NRIX

Simply Wall St.

2 months ago

We're Not Very Worried About Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Rate

NRIX

Zacks

3 months ago

How Much Upside is Left in Nurix Therapeutics (NRIX)? Wall Street Analysts Think 25.27%

NRIX

Zacks

3 months ago

Are You Looking for a Top Momentum Pick? Why Nurix Therapeutics, Inc. (NRIX) is a Great Choice

NRIX

MT Newswires

3 months ago

Barclays Adjusts Price Target on Nurix Therapeutics to $31 From $20, Maintains Overweight Rating

NRIX

MT Newswires

3 months ago

JPMorgan Adjusts Price Target on Nurix Therapeutics to $34 From $31, Maintains Overweight Rating

NRIX

MT Newswires

3 months ago

Needham Adjusts Price Target on Nurix Therapeutics to $29 From $31, Maintains Buy Rating

NRIX

MT Newswires

3 months ago

RBC Lifts Price Target on Nurix Therapeutics to $27 From $26, Keeps Outperform, Speculative Risk

NRIX

Zacks

3 months ago

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates

NRIX

MT Newswires

3 months ago

Nurix Therapeutics Q2 Loss Widens Amid Revenue Decline

Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

NRIX

GlobeNewswire

3 months ago

Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

Nurix Therapeutics to Participate in the UBS Virtual Targeted Protein Degradation (TPD) Day

NRIX

GlobeNewswire

3 months ago

Nurix Therapeutics to Participate in the UBS Virtual Targeted Protein Degradation (TPD) Day

NRIX

Simply Wall St.

4 months ago

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is a favorite amongst institutional investors who own 66%

NRIX

MT Newswires

4 months ago

RBC Raises Price Target on Nurix Therapeutics to $26 From $23, Maintains Outperform, Speculative Risk

Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates

NRIX

Zacks

4 months ago

Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates

NRIX

GuruFocus.com

4 months ago

Insider Sale: CFO Houte Van Sells 20,000 Shares of Nurix Therapeutics Inc (NRIX)

NRIX

MT Newswires

4 months ago

Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing

NRIX

Zacks

4 months ago

Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?

NRIX

MT Newswires

4 months ago

HC Wainwright Raises Price Target on Nurix Therapeutics to $26 From $19, Maintains Buy Rating

Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment

NRIX

Investor's Business Daily

4 months ago

Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment

NRIX

MT Newswires

4 months ago

JPMorgan Adjusts Price Target on Nurix Therapeutics to $31 From $30, Maintains Overweight Rating

NRIX

MT Newswires

4 months ago

Nurix Therapeutics Says Patients Respond Well to Potential Non-Hodgkin Lymphoma Treatment in Phase 1 Trial

$Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)$

NRIX

GlobeNewswire

4 months ago

Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)

NRIX

MT Newswires

4 months ago

Nurix Therapeutics Files Mixed Shelf Registration

Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024)

NRIX

GlobeNewswire

4 months ago

Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024)

Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

NRIX

GlobeNewswire

5 months ago

Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer

NRIX

GlobeNewswire

5 months ago

Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer

NRIX

MT Newswires

5 months ago

Nurix Therapeutics Names New Board Chair

Nurix Therapeutics Announces Board Chair Transition

NRIX

GlobeNewswire

5 months ago

Nurix Therapeutics Announces Board Chair Transition

NRIX

Zacks

5 months ago

Nurix Therapeutics (NRIX) Moves 7.7% Higher: Will This Strength Last?

Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)

NRIX

GlobeNewswire

5 months ago

Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)

NRIX

MT Newswires

5 months ago

Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target

Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

NRIX

GlobeNewswire

5 months ago

Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study

NRIX

Zacks

6 months ago

Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering

Nurix Therapeutics Announces Proposed Public Offering

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics Announces Proposed Public Offering

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

NRIX

Zacks

6 months ago

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

NRIX

Zacks

6 months ago

Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study

NRIX

GuruFocus.com

6 months ago

Nurix Therapeutics Inc (NRIX) Misses Earnings Predictions But Shows Revenue Growth in Q1 Fiscal 2024

NRIX

Zacks

6 months ago

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies

Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6

Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?

NRIX

Zacks

6 months ago

Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?

NRIX

GlobeNewswire

6 months ago

Nurix Therapeutics to Participate in Upcoming Investor Conferences

Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences

NRIX

GlobeNewswire

7 months ago

Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences

Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)

NRIX

GlobeNewswire

7 months ago

Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)

Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting

NRIX

GlobeNewswire

7 months ago

Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting

Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial

NRIX

GlobeNewswire

7 months ago

Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial

NRIX

GlobeNewswire

7 months ago

Nurix Therapeutics to Participate in Upcoming Investor Conferences

Nurix Therapeutics Announces Presentations at the American Association for Cancer Research (AACR) 2024 Annual Meeting

NRIX

GlobeNewswire

7 months ago

Nurix Therapeutics Announces Presentations at the American Association for Cancer Research (AACR) 2024 Annual Meeting

NRIX

Zacks

8 months ago

Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?

Nurix Therapeutics Full Year 2023 Earnings: Misses Expectations

NRIX

Simply Wall St.

8 months ago

Nurix Therapeutics Full Year 2023 Earnings: Misses Expectations

NRIX

GuruFocus.com

8 months ago

Nurix Therapeutics Inc (NRIX) Reports Robust Year-End Financials and Clinical Progress

NRIX

Zacks

8 months ago

Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Misses Revenue Estimates

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update

NRIX

GlobeNewswire

8 months ago

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update

Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

NRIX

Zacks

8 months ago

Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader

NRIX

GlobeNewswire

9 months ago

Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader

NRIX

Zacks

9 months ago

Nurix Therapeutics, Inc. (NRIX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

NETGEAR (NTGR) Reports Q4 Preliminary Results, Stock Up 2%

NRIX

Zacks

9 months ago

NETGEAR (NTGR) Reports Q4 Preliminary Results, Stock Up 2%

Blend Labs, Inc. (NYSE:BLND) surges 13%; retail investors who own 45% shares profited along with institutions

NRIX

Simply Wall St.

9 months ago

Blend Labs, Inc. (NYSE:BLND) surges 13%; retail investors who own 45% shares profited along with institutions

Carrols Restaurant Group (TAST) Rises Yet Lags Behind Market: Some Facts Worth Knowing

NRIX

Zacks

9 months ago

Carrols Restaurant Group (TAST) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Clean Energy to Report Fourth Quarter 2023 Financial Results on February 27; Conference Call to Follow at 1:30 p.m. Pacific Time

NRIX

Business Wire

9 months ago

Clean Energy to Report Fourth Quarter 2023 Financial Results on February 27; Conference Call to Follow at 1:30 p.m. Pacific Time

Are Investors Undervaluing North American Construction Group (NOA) Right Now?

NRIX

Zacks

9 months ago

Are Investors Undervaluing North American Construction Group (NOA) Right Now?

Truist upgrades Sunnova, Enphase on global energy trends

NRIX

Yahoo Finance Video

9 months ago

Truist upgrades Sunnova, Enphase on global energy trends

Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

NRIX

PR Newswire

9 months ago

Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

NRIX

Zacks

9 months ago

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate

Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m

NRIX

Simply Wall St.

9 months ago

Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m

AZZ Inc. Announces Fiscal Year 2024 Third Quarter Cash Dividend of $0.17 per Share

NRIX

PR Newswire

9 months ago

AZZ Inc. Announces Fiscal Year 2024 Third Quarter Cash Dividend of $0.17 per Share

3 Shipping Stocks to Watch From a Challenging Industry

NRIX

Zacks

9 months ago

3 Shipping Stocks to Watch From a Challenging Industry

Despite shrinking by US$73m in the past week, Opera (NASDAQ:OPRA) shareholders are still up 93% over 1 year

NRIX

Simply Wall St.

9 months ago

Despite shrinking by US$73m in the past week, Opera (NASDAQ:OPRA) shareholders are still up 93% over 1 year

$Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL$

NRIX

GlobeNewswire

9 months ago

Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL

The 3 Most Undervalued Flying Car Stocks to Buy in January

NRIX

InvestorPlace

9 months ago

The 3 Most Undervalued Flying Car Stocks to Buy in January

Is Afya Limited's (NASDAQ:AFYA) Latest Stock Performance A Reflection Of Its Financial Health?

NRIX

Simply Wall St.

9 months ago

Is Afya Limited's (NASDAQ:AFYA) Latest Stock Performance A Reflection Of Its Financial Health?

Coinbase, Yum Brands, Chewy: Trending Tickers

NRIX

Yahoo Finance Video

9 months ago

Coinbase, Yum Brands, Chewy: Trending Tickers

AEG and Vivid Seats Announce LA Kings and LA Galaxy Partnership

NRIX

GlobeNewswire

9 months ago

AEG and Vivid Seats Announce LA Kings and LA Galaxy Partnership

With 62% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns

NRIX

Simply Wall St.

9 months ago

With 62% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns

TrustCo to Release Fourth Quarter 2023 Results on January 22, 2024; Conference Call on January 23, 2024

NRIX

GlobeNewswire

9 months ago

TrustCo to Release Fourth Quarter 2023 Results on January 22, 2024; Conference Call on January 23, 2024

Recent Price Trend in AN2 Therapeutics, Inc. (ANTX) is Your Friend, Here's Why

NRIX

Zacks

9 months ago

Recent Price Trend in AN2 Therapeutics, Inc. (ANTX) is Your Friend, Here's Why

Conduent Recognized as ‘GovTech 100’ Company for Third Consecutive Year

NRIX

GlobeNewswire

9 months ago

Conduent Recognized as ‘GovTech 100’ Company for Third Consecutive Year

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?

NRIX

Zacks

9 months ago

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

NRIX

Business Wire

9 months ago

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases

NRIX

GlobeNewswire

9 months ago

Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases

Bausch Health Companies Inc. (NYSE:BHC) is largely controlled by institutional shareholders who own 65% of the company

NRIX

Simply Wall St.

9 months ago

Latest Nurix Therapeutics Inc. Common stock (NRIX) News on October 18, 2024

Share on Social Networks: